Using G6PD tests to enable the safe treatment of Plasmodium vivax infections with primaquine on the Thailand-Myanmar border: A cost-effectiveness analysis

BACKGROUND: Primaquine is the only licensed antimalarial for the radical cure of Plasmodium vivax infections. Many countries, however, do not administer primaquine due to fear of hemolysis in those with glucose-6-phosphate dehydrogenase (G6PD) deficiency. In other settings, primaquine is given witho...

Descripción completa

Detalles Bibliográficos
Autores principales: Devine, Angela, Parmiter, Minnie, Chu, Cindy S., Bancone, Germana, Nosten, François, Price, Ric N., Lubell, Yoel, Yeung, Shunmay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460895/
https://www.ncbi.nlm.nih.gov/pubmed/28542194
http://dx.doi.org/10.1371/journal.pntd.0005602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460895/
https://www.ncbi.nlm.nih.gov/pubmed/28542194
http://dx.doi.org/10.1371/journal.pntd.0005602

Ejemplares similares